Find Research outputs

Search results

• 2018

  Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

  Cunningham, E. B., Amin, J., Feld, J. J., Bruneau, J., Dalgard, O., Powis, J., Hellard, M., Cooper, C., Read, P., Conway, B., Dunlop, A. J., Norton, B., Litwin, A. H., Hajarizadeh, B., Thurnheer, M. C., Dillon, J. F., Weltman, M., Shaw, D., Bruggmann, P., Gane, E. & 8 others, Fraser, C., Marks, P., Applegate, T. L., Quiene, S., Siriragavan, S., Matthews, G. V., Dore, G. J. & Grebely, J., Dec 2018, In: International Journal of Drug Policy. 62, p. 14-23 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • velpatasvir
  • Sofosbuvir
  • Injections
  • Infection
  • Pharmaceutical Preparations
  23 Citations (Scopus)

  98 Downloads (Pure)

• Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial

  Radley, A., de Bruin, M., Inglis, S. K., Donnan, P. T. & Dillon, J. F., 14 Dec 2018, In: BMJ Open. 8, 12, p. 1-8 8 p., e021443.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Opiate Substitution Treatment
  • Hepatitis C
  • Pharmacy
  • Pharmacists
  • Hepacivirus
  7 Citations (Scopus)

  164 Downloads (Pure)

• Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease

  Spanos, C., Maldonado, E. M., Fisher, C. P., Leenutaphong, P., Oviedo-Orta, E., Windridge, D., Salguero, F. J., Bermúdez-Fajardo, A., Weeks, M. E., Evans, C., Corfe, B. M., Rabbani, N., Thornalley, P. J., Miller, M. H., Wang, H., Dillon, J. F., Quaglia, A., Dhawan, A., Fitzpatrick, E. & Moore, J. B., 25 Jun 2018, In: Proteome Science. 16, 13, p. 13 1 p., 13.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  File

  • Proteomics
  • Liver
  • Non-alcoholic Fatty Liver Disease
  133 Downloads (Pure)

• Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymes

  Miller, M. H., Fraser, A., Leggett, G., MacGilchrist, A., Gibson, G., Orr, J., Forrest, E. H., Dow, E., Bartlett, W., Weatherburn, C., Laurell, A., Grant, K., Scott, K., Neville, R. & Dillon, J. F., Jul 2018, In: Frontline Gastroenterology. 9, 3, p. 175-182 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Function Tests
  • Triage
  • Liver Diseases
  • Datasets
  • Primary Health Care
  3 Citations (Scopus)

  272 Downloads (Pure)

• Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK

  Williams, R., Alexander, G., Armstrong, I., Baker, A., Bhala, N., Camps-Walsh, G., Cramp, M. E., de Lusignan, S., Day, N., Dhawan, A., Dillon, J., Drummond, C., Dyson, J., Foster, G., Gilmore, I., Hudson, M., Kelly, D., Langford, A., McDougall, N., Meier, P. & 14 others, Moriarty, K., Newsome, P., O'Grady, J., Pryke, R., Rolfe, L., Rice, P., Rutter, H., Sheron, N., Taylor, A., Thompson, J., Thorburn, D., Verne, J., Wass, J. & Yeoman, A., 17 Mar 2018, In: Lancet. 391, 10125, p. 1097-1107 11 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Cost of Illness
  • Hepatitis
  • Industry
  • Alcohol Drinking
  • Liver Diseases
  70 Citations (Scopus)

  574 Downloads (Pure)

• Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLD

  Brennan, P. N. & Dillon, J. F., Jan 2018, In: Alimentary Pharmacology & Therapeutics. 47, 2, p. 299-300 2 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

• Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2)

  Sharma, R. S., Harrison, D. J., Kisielewski, D., Cassidy, D. M., McNeilly, A. D., Gallagher, J. R., Walsh, S. V., Honda, T., McCrimmon, R. J., Dinkova-Kostova, A. T., Ashford, M. L. J., Dillon, J. F. & Hayes, J. D., 1 Mar 2018, In: CMGH: Cellular and Molecular Gastroenterology and Hepatology. 5, 3, p. 367-398 32 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • TBE 31
  • NF-E2-Related Factor 2
  • Fructose
  • Non-alcoholic Fatty Liver Disease
  • Liver Cirrhosis
  68 Citations (Scopus)

  185 Downloads (Pure)

• Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK

  Williams, R., Alexander, G., Aspinall, R., Batterham, R., Bhala, N., Bosanquet, N., Severi, K., Burton, A., Burton, R., Cramp, M. E., Day, N., Dhawan, A., Dillon, J., Drummond, C., Dyson, J., Foster, G. R., Gilmore, I., Greenberg, J., Henn, C., Hudson, M. & 18 others, Jarvis, H., Kelly, D., Mann, J., McDougall, N., McKee, M., Moriarty, K., Morling, J., Newsome, P., O'Grady, J., Rolfe, L., Rice, P., Rutter, H., Sheron, N., Thorburn, D., Verne, J., Vohra, J., Wass, J. & Yeoman, A., 1 Dec 2018, In: Lancet. 392, 10162, p. 2398-2412 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Diseases
  • Alcohols
  • National Health Programs
  • Obesity
  • England
  28 Citations (Scopus)

  473 Downloads (Pure)

• Guidelines on the management of abnormal liver blood tests

  Newsome, P. N. G., Cramb, R., Davison, S. M., Dillon, J. F., Foulerton, M., Godfrey, E. M., Hall, R., Harrower, U., Hudson, M., Langford, A., Mackie, A., Mitchell-Thain, R., Sennett, K., Sheron, N. C., Verne, J., Walmsley, M. & Yeoman, A., Jan 2018, In: Gut. 67, 1, p. 6-19 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hematologic Tests
  • Guidelines
  • Gastroenterology
  • Liver
  • Biochemistry
  95 Citations (Scopus)

  233 Downloads (Pure)

• Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings: what is required to achieve the WHO's HCV elimination targets?

  Ward, Z., Platt, L., Sweeney, S., Hope, V. D., Maher, L., Hutchinson, S., Palmateer, N., Smith, J., Craine, N., Taylor, A., Martin, N., Ayres, R., Dillon, J., Hickman, M. & Vickerman, P., Sep 2018, In: Addiction. 113, 9, p. 1727-1738 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Opiate Substitution Treatment
  • Hepatitis C
  • Hepacivirus
  • Pharmaceutical Preparations
  • Syringes
  16 Citations (Scopus)

  148 Downloads (Pure)

• Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis

  Wang, H., Swann, R., Thomas, E., Innes, H. A., Valerio, H., Hayes, P. C., Allen, S., Barclay, S. T., Wilks, D., Fox, R., Bhattacharyya, D., Kennedy, N., Morris, J., Fraser, A., Stanley, A. J., Gunson, R., Mclntyre, P. G., Hunt, A., Hutchinson, S. J., Mills, P. R. & 1 others, Dillon, J. F., 1 Aug 2018, In: Journal of Viral Hepatitis. 25, 8, p. 930-938 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Chronic Hepatitis C
  • Hepatitis B
  • Hepacivirus
  • Hepatitis B virus
  • Liver
  5 Citations (Scopus)

  156 Downloads (Pure)

• Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe"

  Fraser, H., Martin, N. K., Brummer-Korvenkontio, H., Carrieri, P., Dalgard, O., Dillon, J., Goldberg, D., Hutchinson, S., Jauffret-Roustide, M., Kåberg, M., Matser, A. A., Matičič, M., Midgard, H., Mravcik, V., Øvrehus, A., Prins, M., Reimer, J., Robaeys, G., Schulte, B., van Santen, D. K. & 3 others, Zimmermann, R., Vickerman, P. & Hickman, M., 1 Mar 2018, In: Journal of Hepatology. 68, 3, p. 402-411 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepacivirus
  • Opiate Substitution Treatment
  • Pharmaceutical Preparations
  • Syringes
  • Slovenia
  56 Citations (Scopus)

  165 Downloads (Pure)

• Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease

  Spanos, C., Maldonado, E. M., Fisher, C. P., Leenutaphong, P., Oviedo-Orta, E., Windridge, D., Salguero, F. J., Bermúdez-Fajardo, A., Weeks, M. E., Evans, C., Corfe, B. M., Rabbani, N., Thornalley, P. J., Miller, M. H., Wang, H., Dillon, J. F., Quaglia, A., Dhawan, A., Fitzpatrick, E. & Bernadette Moore, J., 14 Feb 2018, In: Proteome Science. 16, p. 1-16 16 p., 4.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Proteomics
  • Liver
  • Non-alcoholic Fatty Liver Disease
  • Pyruvaldehyde
  • Biopsy
  12 Citations (Scopus)

  223 Downloads (Pure)

• Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

  Grebely, J., Dalgard, O., Conway, B., Cunningham, E. B., Bruggmann, P., Hajarizadeh, B., Amin, J., Bruneau, J., Hellard, M., Litwin, A. H., Marks, P., Quiene, S., Siriragavan, S., Applegate, T. L., Swan, T., Byrne, J., Lacalamita, M., Dunlop, A., Matthews, G. V., Powis, J. & 12 others, Shaw, D., Thurnheer, M. C., Weltman, M., Kronborg, I., Cooper, C., Feld, J. J., Fraser, C., Dillon, J. F., Read, P., Gane, E., Dore, G. J. & on behalf of the SIMPLIFY Study Group, Mar 2018, In: Lancet Gastroenterology and Hepatology. 3, 3, p. 153-161 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • velpatasvir
  • Sofosbuvir
  • Hepacivirus
  • Multicenter Studies
  • Virus Diseases
  111 Citations (Scopus)

  455 Downloads (Pure)

• The Addition of Vitamin D Supplementation to Interferon and Ribavirin in the Treatment of Hepatitis C Virus Infection: A Randomised Double-Blind PlaceboControlled Pilot Study

  Coats, J. T., Hapca, A., Witham, M., Donnan, P., Heydtmann, M., Bathgate, A., Hayes, P. C., Fraser, A., Evans, M., Leen, C., Bramley, P., Barclay, S. T., Fox, R. & Dillon, J. F., 2018, In: Archives of Gastroenterology and Hepatology. 1, 2, p. 39-48 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Ribavirin
  • Sustained Virologic Response
  • Vitamin D
  • Hepacivirus
  • Interferons
  6 Downloads (Pure)

• The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations

  Lazarus, J. V., Safreed-Harmon, K., Thursz, M. R., Dillon, J. F., El-Sayed, M. H., Elsharkawy, A. M., Hatzakis, A., Jadoul, M., Prestileo, T., Razavi, H., Rockstroh, J. K., Wiktor, S. Z. & Colombo, M., 1 Aug 2018, In: Seminars in Liver Disease. 38, 3, p. 181-192 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Hepacivirus
  • Population
  • Prisoners
  • Health Services Needs and Demand
  68 Citations (Scopus)

  125 Downloads (Pure)

• The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: role of the treatment regimen

  Innes, H. A., Barclay, S. T., Hayes, P. C., Fraser, A., Dillon, J. F., Stanley, A. J., Bathgate, A., McDonald, S. A., Goldberg, D., Valerio, H., Fox, R., Kennedy, N., Bramley, P. & Hutchinson, S. J., Apr 2018, In: Journal of Hepatology. 68, 4, p. 646-654 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Hepatocellular Carcinoma
  • Interferons
  • Liver Neoplasms
  • Hepacivirus
  37 Citations (Scopus)

  205 Downloads (Pure)
• 2016

  A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy

  Aspinall, E. J., Mitchell, W., Schofield, J., Cairns, A., Lamond, S., Bramley, P., Peters, S. E., Valerio, H., Tomnay, J., Goldberg, D. J., Mills, P. R., Barclay, S. T., Fraser, A., Dillon, J. F., Martin, N. K., Hickman, M. & Hutchinson, S. J., Dec 2016, In: Journal of Viral Hepatitis. 23, 12, p. 1009-1016 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Prisons
  • Hepatitis C
  • Prisoners
  • Therapeutics
  • Antiviral Agents
  28 Citations (Scopus)

  207 Downloads (Pure)

• Gamma glutamyl transferase "To be or not to be" a Liver function test?

  Dillon, J. F. & Miller, M. H., 1 Nov 2016, In: Annals of Clinical Biochemistry. 53, 6, p. 629-631 3 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

  File
  3 Citations (Scopus)

  228 Downloads (Pure)

• Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs

  Weir, A., McLeod, A., Innes, H., Valerio, H., Aspinall, E. J., Goldberg, D. J., Barclay, S. T., Dillon, J. F., Fox, R., Fraser, A., Hayes, P. C., Kennedy, N., Mills, P. R., Stanley, A. J., Aitken, C., Gunson, R., Templeton, K., Hunt, A., McIntyre, P. & Hutchinson, S. J., 1 Aug 2016, In: Drug and Alcohol Dependence. 165, p. 53-60 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Viruses
  • Hepacivirus
  • Pharmaceutical Preparations
  • RNA
  29 Citations (Scopus)

  311 Downloads (Pure)

• MAIT cells are activated during human viral infections

  Van Wilgenburg, B., Scherwitzl, I., Hutchinson, E. C., Leng, T., Kurioka, A., Kulicke, C., De Lara, C., Cole, S., Vasanawathana, S., Limpitikul, W., Malasit, P., Young, D., Denney, L., Moore, M. D., Fabris, P., Giordani, M. T., Oo, Y. H., Laidlaw, S. M., Dustin, L. B., Ho, L. P. & 35 others, Thompson, F. M., Ramamurthy, N., Mongkolsapaya, J., Willberg, C. B., Screaton, G. R., Klenerman, P., Barnes, E., Ball, J., Burgess, G., Cooke, G., Dillon, J., Gore, C., Foster, G., Guha, N., Halford, R., Herath, C., Holmes, C., Howe, A., Hudson, E., Irving, W., Khakoo, S., Koletzki, D., Martin, N., Mbisa, T., McKeating, J., McLauchlan, J., Miners, A., Murray, A., Shaw, P., Simmonds, P., Spencer, C., Targett-Adams, P., Thomson, E., Vickerman, P. & Zitzmann, N., 23 Jun 2016, In: Nature Communications. 7, 11653.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Mucosal-Associated Invariant T Cells
  • T-cells
  • infectious diseases
  • Virus Diseases
  • activation
  205 Citations (Scopus)

  318 Downloads (Pure)

• Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication

  Leask, J. D. & Dillon, J. F., Jul 2016, In: Alimentary Pharmacology & Therapeutics. 44, 2, p. 145-156 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Hepatitis C
  • Hepacivirus
  • Pharmaceutical Preparations
  • Therapeutics
  • Prisoners
  10 Citations (Scopus)

  175 Downloads (Pure)

• 'Standing Outside the Junkie Door'-service users' experiences of using community pharmacies to access treatment for opioid dependency

  Radley, A., Melville, K., Easton, P., Williams, B. & Dillon, J. F., Dec 2016, In: Journal of Public Health. 39, 4, p. 846-855 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Pharmacies
  • Dependency (Psychology)
  • Opioid Analgesics
  • Opiate Substitution Treatment
  • Respect
  8 Citations (Scopus)

  203 Downloads (Pure)

• The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α

  Orr, J. G., Currie, C. J., Berni, E., Goel, A., Moriarty, K. J., Sinha, A., Gordon, F., Dethier, A., Dillon, J., Clark, K., Richardson, P., Middleton, P., Patel, V., Shawcross, D., Preedy, H., Aspinall, R. J. & Hudson, M., Sep 2016, In: Liver International. 36, 9, p. 1295-1303 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Rifaximin
  • Hepatic Encephalopathy
  • Length of Stay
  • Drug Costs
  • Therapeutics
  26 Citations (Scopus)

  200 Downloads (Pure)

• The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large ‘real world’ cohort

  Wang, H., Innes, H., Hutchinson, S. J., Goldberg, D. J., Allen, S., Barclay, S. T., Bramley, P., Fox, R., Fraser, A., Hayes, P. C., Kennedy, N., Mills, P. R. & Dillon, J. F., Apr 2016, In: European Journal of Gastroenterology & Hepatology. 28, 4, p. 398-404 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Leukopenia
  • Hepatitis C
  • Thrombocytopenia
  • Anemia
  • Therapeutics
  1 Citation (Scopus)
• 2014

  Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan

  Mcdonald, S. A., Hutchinson, S. J., Innes, H. A., Allen, S., Bramley, P., Bhattacharyya, D., Carman, W., Dillon, J. F., Fox, R., Fraser, A., Goldberg, D. J., Kennedy, N., Mills, P. R., Morris, J., Stanley, A. J., Wilks, D. & Hayes, P. C., May 2014, In: Journal of Viral Hepatitis. 21, 5, p. 366-376 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Scotland
  • Hepatitis C
  • Hepatitis
  • Antiviral Agents
  • Ambulatory Care Facilities
  15 Citations (Scopus)

• Commentary: Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B

  Miller, M., Heron, T. & Dillon, J., 2014, In: Alimentary Pharmacology & Therapeutics. 39, 10, p. 1236 12704.

  Research output: Contribution to journal › Article › peer-review
  1 Citation (Scopus)

• Commentary: real-world triple therapy experience treating hepatitis C virus

  Heron, T., Miller, M. H. & Dillon, J. F., Mar 2014, In: Alimentary Pharmacology & Therapeutics. 39, 5, p. 542 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  1 Citation (Scopus)

• Disorders of the liver

  Polignano, F. M., Dillon, J. F., Zealley, I. A., Quyn, A. J., Smith, A. & Cuschieri, S. A., 28 Nov 2014, Essential Surgical Practice: Higher Surgical Training in General Surgery. Cuschieri, A. & Hanna, G. (eds.). 5 ed. London: CRC Press, p. 616-670 55 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Round Ligaments
  • Liver
  • Veins
  • Portal System
  • Yolk Sac
  1 Citation (Scopus)

• Eradicating hepatitis C is a realistic aim

  Ryder, S. & Dillon, J., 9 May 2014, In: Health Service Journal. 124, 6397, p. 21-23 3 p.

  Research output: Contribution to journal › Article › peer-review
  1 Citation (Scopus)

• Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation model

  Innes, H., Goldberg, D., Dusheiko, G., Hayes, P., Mills, P. R., Dillon, J. F., Aspinall, E., Barclay, S. T. & Hutchinson, S. J., 2014, In: Journal of Hepatology. 60, 6, p. 1118-1126 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Hepacivirus
  • Liver Failure
  • Liver Diseases
  • Fibrosis
  • Patient Simulation
  15 Citations (Scopus)

• Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts

  McLernon, D. J., Donnan, P. T., Sullivan, F. M., Roderick, P., Rosenberg, W. M., Ryder, S. D. & Dillon, J. F., 2 Jun 2014, In: BMJ Open. 4, 6, 10 p., e004837.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver Function Tests
  • Liver Diseases
  • Primary Health Care
  • Population
  • Scotland
  12 Citations (Scopus)

  207 Downloads (Pure)

• Proteomic and genomic studies of non-alcoholic fatty liver disease - clues in the pathogenesis

  Lim, J. W., Dillon, J. & Miller, M., 14 Jul 2014, In: World Journal of Gastroenterology . 20, 26, p. 8325-8340 16 p.

  Research output: Contribution to journal › Article › peer-review

  • Non-alcoholic Fatty Liver Disease
  • Proteomics
  • Liver
  • Fibrosis
  • Acute-Phase Reaction
  28 Citations (Scopus)

• Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy

  Miller, M. H., Agarwal, K., Austin, A., Brown, A., Barclay, S. T., Dundas, P., Dusheiko, G. M., Foster, G. R., Fox, R., Hayes, P. C., Leen, C., Millson, C., Ryder, S. D., Tait, J., Ustianowski, A. & Dillon, J. F., Jun 2014, In: Alimentary Pharmacology & Therapeutics. 39, 12, p. 1363-1375 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Hepatitis C
  • Consensus
  • Hepacivirus
  • Guidelines
  • Chronic Hepatitis C
  36 Citations (Scopus)

• Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes, but not with insulin resistance

  Meakin, P. J., Chowdhry, S., Sharma, R. S., Ashford, F. B., Walsh, S. V., McCrimmon, R. J., Dinkova-Kostova, A. T., Dillon, J. F., Hayes, J. D. & Ashford, M. L. J., Sep 2014, In: Molecular and Cellular Biology. 34, 17, p. 3305-3320 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • NF-E2-Related Factor 2
  • Unfolded Protein Response
  • Fatty Liver
  • High Fat Diet
  • Insulin Resistance
  107 Citations (Scopus)

  356 Downloads (Pure)

• The serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis

  Miller, M. H., Walsh, S. V., Atirh, A., Huang, J. T-J., Ferguson, M. A. J. & Dillon, J. F., Oct 2014, In: Journal of Gastroenterology and Hepatology. 29, 10, p. 1839-1847 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Non-alcoholic Fatty Liver Disease
  • Proteome
  • Biomarkers
  • Serum
  • Proteomics
  23 Citations (Scopus)

• Update on the treatment of hepatitis C genotypes 2-6

  Paterson, J. C. M., Miller, M. H. & Dillon, J. F., Dec 2014, In: Current Opinion in Infectious Diseases. 27, 6, p. 540-544 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Hepatitis C
  • Genotype
  • Antiviral Agents
  • Global Health
  • Interferons
  5 Citations (Scopus)

• Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland

  McAllister, G., Innes, H., Mcleod, A., Dillon, J. F., Hayes, P. C., Fox, R., Barclay, S. T., Templeton, K., Aitken, C., Gunson, R., Goldberg, D. & Hutchinson, S. J., Nov 2014, In: Journal of Clinical Virology . 61, 3, p. 359-364 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Scotland
  • Hepatitis C
  • Specimen Handling
  • Pharmaceutical Preparations
  • Phlebotomy
  30 Citations (Scopus)
• 2012

  HCV research UK: a UK national resource to support research into HCV infection

  Irving, W., McLauchlan, J., Foster, G., Dillon, J., Hutchinson, S. & Wilkes, B., Jul 2012, In: Gut. 61, Suppl. 2, p. A147-A148 2 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection

  Jafferbhoy, H., Miller, M. H., Dunbar, J. K., Tait, J., Mcleod, S. & Dillon, J. F., Feb 2012, In: Journal of Viral Hepatitis. 19, 2, p. 112-119 8 p.

  Research output: Contribution to journal › Article › peer-review
  12 Citations (Scopus)

• Is travel-time to a specialist centre a risk factor for non-referral, non-attendance and loss to follow-up among patients with hepatitis C (HCV) infection?

  Astell-Burt, T., Flowerdew, R., Boyle, P. & Dillon, J., 1 Jan 2012, In: Social Science and Medicine.

  Research output: Contribution to journal › Article › peer-review

  • Time Travel
  • Virus
  • Hepatitis C
  • contagious disease
  • Hepacivirus
  14 Citations (Scopus)

• Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant

  Palmer, C. N. A., Maglio, C., Pirazzi, C., Burza, M. A., Adiels, M., Burch, L., Donnelly, L. A., Colhoun, H., Doney, A. S., Dillon, J. F., Pearson, E. R., McCarthy, M., Hattersley, A. T., Frayling, T., Morris, A. D., Peltonen, M., Svensson, P-A., Jacobson, P., Borén, J., Sjöström, L. & 2 others, Carlsson, L. M. S. & Romeo, S., 2012, In: PLoS ONE. 7, 6, e39362.

  Research output: Contribution to journal › Article › peer-review

  • patatin
  • noninsulin-dependent diabetes mellitus
  • Phospholipases
  • Medical problems
  • phospholipases
  63 Citations (Scopus)

• Quantifying the extent of cirrhosis attributable to alcohol among patients chronically infected with hepatitis c: implications for treatment cost-effectiveness studies

  Innes, H. A., Hutchinson, S. J., Amanda, W., Dillon, J. F., Goldberg, D. J., Mills, P. R., Morris, J., Stanley, A., Hayes, P. & Hepatitis C Clinical Database Moni, Apr 2012, In: Journal of Hepatology. 56, p. S441-S441 1 p.

  Research output: Contribution to journal › Special issue › peer-review
  64 Citations (Scopus)

• Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland

  Innes, H. A., Hutchinson, S. J., Allen, S., Bhattacharyya, D., Bramley, P., Carman, B., Delahooke, T. E. S., Dillon, J. F., Goldberg, D. J., Kennedy, N., Mills, P. R., Morris, J., Morris, J., Robertson, C., Stanley, A. J., Hayes, P. & Hepatitis C Clinical Database, 2012, In: European Journal of Gastroenterology & Hepatology. 24, 6, p. 646-655 10 p.

  Research output: Contribution to journal › Article › peer-review
  27 Citations (Scopus)

• Spontaneous bacterial peritonitis prophylaxis in the era of healthcare associated infection

  Jafferbhoy, H. M., Miller, M. H., Gashau, W., ChandraShekar, C., Henry, E. B., Lockhart, M. & Dillon, J. F., 2012, In: Gut. 61, 11, p. 1644-1645 2 p.

  Research output: Contribution to journal › Letter › peer-review
  2 Citations (Scopus)

• The effectiveness of outreach testing for hepatitis C in an immigrant Pakistani population

  Jafferbhoy, H., Miller, M. H., McIntyre, P. & Dillon, J. F., 2012, In: Epidemiology and Infection. 140, 6, p. 1048-1053 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Hepatitis C
  • Hepacivirus
  • Population
  • Scotland
  • Chronic Hepatitis B
  14 Citations (Scopus)

• The Utility of Liver Function Tests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI)

  McLernon, D. J., Dillon, J. F., Sullivan, F. M., Donnan, P. T., Roderick, P., Rosenberg, W. M. & Ryder, S. D., 14 Dec 2012, In: PLoS ONE. 7, 12, e50965.

  Research output: Contribution to journal › Article › peer-review

  • liver function tests
  • liver function
  • Liver
  • Liver Function Tests
  • Primary Health Care
  11 Citations (Scopus)

• UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

  Ramachandran, P., Fraser, A., Agarwal, K., Austin, A., Brown, A., Foster, G. R., Fox, R., Hayes, P. C., Leen, C., Mills, P. R., Mutimer, D. J., Ryder, S. D. & Dillon, J. F., 2012, In: Alimentary Pharmacology & Therapeutics. 35, 6, p. 647-662 16 p.

  Research output: Contribution to journal › Article › peer-review

  • N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
  • telaprevir
  • Chronic Hepatitis C
  • Protease Inhibitors
  • Consensus
  87 Citations (Scopus)
• 2011

  A genome-wide association study identifies potential susceptibility Loci for hepatotoxicity due to various drugs

  Urban, T., Shen, Y., Chalasani, N. P., Fontana, R. J., Rochon, J., Stolz, A., Serrano, J. A., Aithal, G. P., Daly, A., Dillon, J. F., Floraros, A., Molokhia, M., Lucena, M. I., Goldstein, D. B. & Watkins, P. B., May 2011, In: Gastroenterology. 140, 5 Suppl. 1, p. S886-S886 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota

  Steed, H., Macfarlane, G. T., Blackett, K. L., Macfarlane, S., Miller, M. H., Bahrami, B. & Dillon, J. F., Dec 2011, In: FEMS Immunology and Medical Microbiology. 63, 3, p. 346-354 9 p.

  Research output: Contribution to journal › Article › peer-review
  15 Citations (Scopus)